Don Lamm, MD, FACS, Director, BCG Oncology Clinical Professor, University of Arizona, Phoenix, Arizona, presented a lecture at the New Technologies and Innovative Treatment Strategies for Genitourinary Malignancies meeting, held September 28-30, 2007, in San Diego. The program is intended for healthcare specialists involved in diagnosing and treating genitourinary diseases.

Don Lamm, MD, FACS, Director, BCG Oncology Clinical Professor, University of Arizona, Phoenix, Arizona, presented a lecture at the New Technologies and Innovative Treatment Strategies for Genitourinary Malignancies meeting, held September 28-30, 2007, in San Diego. The program is intended for healthcare specialists involved in diagnosing and treating genitourinary diseases.

Timothy G. Wilson, MD, Chair, Pauline and Martin Collins Family Chair in Urology Associate Professor, Surgery Director, Department of Urology & Urologic Oncology Director, Prostate Cancer Program, City of Hope National Cancer Center, Duarte, California, presented a lecture at the New Technologies and Innovative Treatment Strategies for Genitourinary Malignancies meeting, held September 28-30, 2007, in San Diego. The program is intended for healthcare specialists involved in diagnosing and treating genitourinary diseases.

Przemek Twardowski, MD, Assistant Professor Division of Medical Oncology & Therapeutics Research, City of Hope National Cancer Center, Duarte, California, presented a lecture at the New Technologies and Innovative Treatment Strategies for Genitourinary Malignancies meeting, held September 28-30, 2007, in San Diego. The program is intended for healthcare specialists involved in diagnosing and treating genitourinary diseases.

Victor E. Reuter, MD, Vice Chair, Department of Pathology, Director, Immunohistochemistry Core Facility, Memorial Sloan-Kettering Cancer Center, New York, New York, presented a lecture at the New Technologies and Innovative Treatment Strategies for Genitourinary Malignancies meeting, held September 28-30, 2007, in San Diego. The program is intended for healthcare specialists involved in diagnosing and treating genitourinary diseases.

Jeffrey Yoshida, MD, Urologic Oncologist, Division of Surgery, City of Hope National Cancer Center, Duarte, California, presented a lecture at the New Technologies and Innovative Treatment Strategies for Genitourinary Malignancies meeting, held September 28-30, 2007, in San Diego. The program is intended for healthcare specialists involved in diagnosing and treating genitourinary diseases.

Christopher G. Wood, MD, FACS, Associate Professor of Urology and Cancer Biology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, presented a lecture at the New Technologies and Innovative Treatment Strategies for Genitourinary Malignancies meeting, held September 28-30, 2007, in San Diego. The program is intended for healthcare specialists involved in diagnosing and treating genitourinary diseases.

Kim A. Margolin, MD, Associate Director for Clinical Research, Division of Medical Oncology & Therapeutics Research; Professor, Division of Hematology & Hematopoietic Cell Transplantation Staff Physician, Medical Oncology, City of Hope National Cancer Center, Duarte, California, presented a lecture at the New Technologies and Innovative Treatment Strategies for Genitourinary Malignancies meeting, held September 28-30, 2007, in San Diego. The program is intended for healthcare specialists involved in diagnosing and treating genitourinary diseases.

Robert A. Figlin, MD, FACP, Associate Director for Clinical Research, Comprehensive Cancer Center, Chair, Divison of Medical Oncology and Therapeutics Research Arthur and Rosalie Kaplan Professor of Medical Oncology, City of Hope National Cancer Center, Duarte, California, presented a lecture at the New Technologies and Innovative Treatment Strategies for Genitourinary Malignancies meeting, held September 28-30, 2007, in San Diego. The program is intended for healthcare specialists involved in diagnosing and treating genitourinary diseases.

James A. Lugg, MD, Assistant Clinical Professor, and Assistant Course Director for at Cryotherapy Workshops, at the University of Colorado in Denver, presents a lecture on the prevalence and treatment of overactive bladder.

E. David Crawford, MD, Professor of Surgery and Radiation and Oncology Head, Urologic Oncology at the University of Colorado Health Sciences Center in Denver, Colorado, presents a lecture on the use of targeted therapy for the treatment of prostate cancer.